Literature DB >> 1262169

The effect of dopamine on the intraocular pressure and pupil of the rabbit eye.

R P Shannon, A Mead, M L Sears.   

Abstract

The presence of a dopamine-specific receptor that can influence intraocular pressure in the rabbit eye is suggested by these experiments: intravitreal, systemic, or topically administered dopamine solutions can produce a decrease in intraocular pressure that is dose-dependent. In high doses the decrease in intraocular pressure is accompanied by mydriasis, and alpha-adrenergic pupillary response. This alpha-response may be caused by dopamine as a direct, but weak alpha-stimulator or by displacement of norepinephrine onto the receptor from its storage site. At lower doses the decrease in intraocular pressure occurs in the absence of mydriasis and in spite of blockade of beta-adrenergic receptors. Further, a specific dopaminergic blocker, haloperidol, prevents this decrease in intraocular pressure. The decreases are small, but reproducible and suggest that dopamine can influence the adrenergic regulation of intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262169

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  8 in total

1.  The effects of dopamine, haloperidol and bromocriptine on intraocular pressure.

Authors:  O Elibol; C Güler; N Yüksel
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

2.  The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).

Authors:  M R Al-Sereiti; P Turner
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.

Authors:  O Bartošová; C Bonnet; O Ulmanová; M Šíma; F Perlík; E Růžička; O Slanař
Journal:  J Neural Transm (Vienna)       Date:  2017-12-19       Impact factor: 3.575

4.  Quantitative Evaluation of Pupil Responses in Patients with Prolactinomas Being Treated with Dopamine Agonists.

Authors:  Sedat Ava; Leyla Hazar; Mine Karahan; Seyfettin Erdem; Mehmet Emin Dursun; Zafer Pekkolay; Uğur Keklikçi
Journal:  Neuroophthalmology       Date:  2022-01-25

5.  Dopamine, dopaminergic drugs and ocular hypertension.

Authors:  M Virno; A Gazzaniga; L Taverniti; J Pecori Giraldi; F De Gregorio
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

6.  Effect of beta-phenylethylamine on intraocular pressure.

Authors:  S Miyake; H Ichikawa; K Yagi
Journal:  Experientia       Date:  1979-05-15

7.  Decoding the brain state-dependent relationship between pupil dynamics and resting state fMRI signal fluctuation.

Authors:  Filip Sobczak; Patricia Pais-Roldán; Kengo Takahashi; Xin Yu
Journal:  Elife       Date:  2021-08-31       Impact factor: 8.140

Review 8.  Role of dopaminergic receptors in glaucomatous disease modulation.

Authors:  Nicola Pescosolido; Francesco Parisi; Paola Russo; Giuseppe Buomprisco; Marcella Nebbioso
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.